Anti-inflammatory effects of sulfuretin from Rhus verniciflua Stokes via the induction of heme oxygenase-1 expression in murine macrophages

International Immunopharmacology

Volumn 10, Issue 8, 2010, Pages 850-858

  Lee, Dong Sung ^a   Jeong, Gil Saeng ^a   Li, Bin ^a   Park, Hyun ^a   Kim, Youn Chul ^a  

^a Wonkwang University   (South Korea)

Author keywords

Anti inflammatory effects; Heme oxygenase (HO) 1; Murine peritoneal macrophage; RAW264.7 macrophages; Rhus verniciflua; Sulfuretin

Indexed keywords

CYCLOOXYGENASE 2; FLAVONOID; HEME OXYGENASE 1; I KAPPA B ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROTOPORPHYRIN TIN; SULFURETIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANACARDIACEAE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RHUS VERNICIFLUA STOKES;

ACTIVE TRANSPORT, CELL NUCLEUS; ANACARDIACEAE; ANIMALS; BENZOFURANS; CELL LINE; CELL NUCLEUS; CYCLOOXYGENASE 2; DINOPROSTONE; FLAVONOIDS; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MEDICINE, EAST ASIAN TRADITIONAL; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954955356     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.019     Document Type: Article

References (49)

1. Kim T.J. Korea resource plants, vol. II 1996, 292-297. Seoul University Press, Seoul, Korea.
2. Lee J.C., Lee K.Y., Kim J., Na C.S., Jung N.C., Chung G.H., et al. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol 2004, 42:1383-1388.
3. Lee J.C., Kim J., Lim K.T., Yang M.S., Jang Y.S. Ethanol eluted extract of Rhus verniciflua Stokes showed both antioxidant and cytotoxic effects on mouse thymocytes depending on the dose and time of the treatment. Biochem Mol Biol 2001, 34:250-258.
4. Lim K.T., Hu C., Kitts D.D. Antioxidant activity of a Rhus verniciflua Stokes ethanol extract. Food Chem Toxicol 2001, 39:229-237.
5. Jeon W.K., Kim J.H., Lee A.Y., Kim H.K. Inhibition of whole blood platelet aggregation from traditional medicines. Kor J Orient Med 2003, 9:55-67.
6. Kim I.T., Park Y.M., Shin K.M., Ha J.H., Choi J.W., Jung H.J., et al. Anti-inflammatory and anti-nociceptive effects of the extract from Kalopanax pictus, Pueraria thunbergiana and Rhus verniciflua. J Ethnopharmacol 2004, 94:165-173.
7. Park K.Y., Jung G.O., Lee K.T., Choi J.W., Choi M.Y., Kim G.T., et al. Antimutagenic activity of flavonoids from the heartwood of Rhus verniciflua. J Ethnopharmacol 2004, 90:73-79.
8. Lee J.C., Lim K.T., Jang Y.S. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochim Biophys Acta 2002, 1570:181-191.
9. Son Y.O., Lee K.Y., Lee J.C., Jang H.S., Kim J.G., Jeon Y.M., et al. Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines. Toxicol Lett 2005, 155:115-125.
10. Ko J.H., Lee S.J., Lim K.T. 36-kDa glycoprotein isolated from Rhus verniciflua Stokes fruit has a protective activity to glucose/glucose oxidase-induced apoptosis in NIH/3T3 cells. Toxicol in Vitro 2005, 19:353-363.
11. Trenam C.W., Blake D.R., Morris C.J. Skin inflammation: reactive oxygen species and the role of iron. J Invest Dermatol 1992, 99:675-682.
12. Morse D., Choi A.M. Heme oxygenase-1: the emerging molecule has arrived. Am J Respir Cell Mol Biol 2002, 27:8-16.
13. Llesuy S.F., Tomaro M.L. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1994, 1223:9-14.
14. Balogun E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., et al. Curcumin activates the heme oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 2003, 371:887-895.
15. Jaiswal A.K. Regulation of genes encoding NAD(P)H:quinine oxidoreductases. Free Radical Biol Med 2000, 29:254-262.
16. Lee T.S., Tsai H.L., Chau L.Y. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflamatory effect of low dose 15-deoxy-delta-12, 14-prostaglandin J2. J Biol Chem 2003, 278:19325-19330.
17. Wiesel P., Foster L.C., Pellacani A., Layne M.D., Hsieh C.M., Huggins G.S. Thioredoxin facilitates the induction of heme oxygenase-1 in response to infl ammatory mediators. J Biol Chem 2000, 275:24840-24846.
18. Morse D., Pischke S.E., Zhou Z., Davis R.J., Flavell R.A., Loop T. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003, 278:36993-36998.
19. Rushworth S.A., Chen X.L., Mackman N., Ogborne R.M., O'Connell M.A. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol 2005, 175:4408-4415.
20. Suh G.Y., Jin Y., Yi A.K., Wang X.M., Choi A.M. CCAAT/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2. Am J Respir Cell Mol Biol 2006, 35:220-226.
21. Oh G.S., Pae H.O., Lee B.S., Kim B.N., Kim J.M., Kim H.R., et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radical Biol Med 2006, 41:106-119.
22. Oh G.S., Pae H.O., Choi B.M., Chae S.C., Lee H.S., Ryu D.G. 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2, 3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem Biophys Res Commun 2004, 320:1156-1162.
23. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006, 86:583-650.
24. Jeong G.S., Lee D.S., Kim Y.C. Cudratricusxanthone A from Cudrania tricuspidata suppresses pro-inflammatory mediators through expression of anti-inflammatory heme oxygenase-1 in RAW264.7 macrophages. Int Immunopharm 2009, 9:241-246.
25. Jung M.J., Chung H.Y., Kang S.S., Choi J.H., Bae K.S., Choi J.S. Antioxidant activity from the stem bark of Albizzia julibrissin. Arch Pharm Res 2003, 26:458-462.
26. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993, 303:474-482.
27. Narumi S., Finke J.H., Hamilton T.A. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem 1990, 265:7036-7041.
28. Titheradge M.A. The enzymatic measurement of nitrate and nitrite. Meth Mol Biol 1998, 303:474-482.
29. Sawle P., Foresti R., Mann B.E., Johnson T.R., Green C.J., Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005, 145:800-810.
30. Motterlini R., Foresti R., Intaglietta M., Winslow R.M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996, 270:H107-H114.
31. Sato K., Balla J., Otterbein L., Smith R.N., Brouard S., Lin Y., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001, 166:4185-4194.
32. Numazawa S., Ishikawa M., Yoshida A., Tanaka S., Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 2003, 285:C334-C342.
33. Kim J.B. Identification of antioxidative component from stem bark of Rhus verniciflua. Korean J Food Nutr 2003, 16:60-65.
34. Gao Z., Huang K., Yang X., Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1999, 1472:643-650.
35. Wong W.S., McLean A.E. Effects of phenolic antioxidants and flavonoids on DNA synthesis in rat liver, spleen, and testis in vitro. Toxicology 1999, 139:243-253.
36. Lee S.H., Seo G.S., Sohn D.H. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW264.7 cells. J Ethnopharmacol 2004, 323:125-132.
37. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988, 333:664-666.
38. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004, 75:639-653.
39. Mason N.A., Springall D.R., Pomerance A., Evans T.J., Yacoub M.H., Polak J.M. Expression of inducible nitric oxide synthase and formation of peroxynitrite in posttransplant obliterative bronchiolitis. J Heart Lung Transplant 1998, 17:710-714.
40. Smith D., Hansch H., Bancroft G., Ehlers S. T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factoralpha and interferon-gamma. Immunology 1997, 92:413-421.
41. Thanos D., Maniatis T. Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 1995, 15:152-164.
42. Choi M.S., Lee S.H., Cho H.S., Kim Y., Yun Y.P., Jung H.Y., et al. Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells. Eur J Pharmacol 2007, 556:181-189.
43. Kim B.H., Cho S.M., Reddy A.M., Kim Y.S., Min K.R., Kim Y. Down-regulatory effect of quercitrin gallate on nuclear factor-kappa B-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7. Biochem Pharmacol 2005, 69:1577-1583.
44. Kim H.G., Shrestha B., Lim S.Y., Yoon D.H., Chang W.C., Shin D.J., et al. Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW264.7 macrophage cells. Eur J Pharmacol 2006, 545:192-199.
45. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004, 165:1045-1053.
46. Mannaioni P.F., Vannacci A., Masini E. Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity. Inflamm Res 2006, 55:261-273.
47. Wu L., Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005, 57:585-630.
48. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003, 24:449-455.
49. Prawan A., Kundu J.K., Surh Y.J. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal 2005, 7:1688-1703.